AcuCort AB

AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in severe and acute allergic reactions, among other things. The goal is commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Quotes for AcuCort AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Jonas Jönmark

Chairperson of the Board

  • Ebba Fåhraeus

Board

  • Anna Eriksrud
  • Göran Tornling
  • Helen Ljungdahl Round
  • Jan Poulsen
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Intervju med AcuCorts VD Mats Lindfors

    AcuCort - Life Sciencedagen 2019

    AcuCort är redo för avgörande bioekvivalensstudier och informerar om nyemission

    AcuCort ger statusuppdatering och siktar på marknad

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 31,01 31,01 2025-06-26
    Jan Sören Poulsen 7,29 7,29 2025-06-26
    Aqilion AB 5,01 5,01 2025-06-26
    Olle Florén med bolag 2,71 2,71 2025-06-26
    Sven Jonmark 1,93 1,93 2025-06-26
    Bengt Schager 1,76 1,76 2025-06-26
    Olle Olsson 1,42 1,42 2025-06-26
    Johan Thorell 1,41 1,41 2025-06-26
    Nordnet Pensionsförsäkring 1,30 1,30 2025-06-26
    Göran Ofsén 1,15 1,15 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-11-14 Delårsrapport 2025-Q3

    Annual reports, prospectus etc.